Health Care · Euronext Brussels · FYE 12-31 · Prices AT CLOSE 2026-07-28 (EUR) — end-of-day, never a live or intraday quote
Last €772.00Day −2.25%Mkt cap $53.8B1Y +50.8%Off 52W high −7.4%Vol (1Y) 34.0%
Daily closing price, split-adjusted to the current basis; 2.9y shown of 2,515 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
No fair-value, short-interest or ownership figures on file for ARGX.BR.
| Sales (TTM)$4.25B |
| Earnings (TTM)$1.29B |
| ROE20.2% |
| Net margin30.4% |
| ROIC26.9% |
| Sales growth 3Y112.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+7.7% |
| 1Y+50.8% |
| 3Y+70.0% |
| 5Y+200.9% |
| 10Y+5907.8% |
| Since incept. (ann.)+50.9% |
Total return through 2026-07-28 · series begins 2016-07-20. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)34.0% |
| Ann. volatility (3Y)37.9% |
| Sharpe (1Y)1.39 |
| Sharpe (3Y)0.66 |
| Max drawdown (1Y)−27.4% |
| Max drawdown (3Y)−39.3% |
| Beta (3Y vs SPY)0.24 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for ARGX.BR.
No reported quarters on file for ARGX.BR.
